{"id":"NCT01667471","sponsor":"Hoffmann-La Roche","briefTitle":"A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis Who Completed WA19977 Core Study","officialTitle":"Long-term, Interventional, Open Label Extension Study Evaluating the Safety of Tocilizumab Treatment in Patients With Polyarticular-course Juvenile Idiopathic Arthritis Who Completed the Global, Multinational Trial (WA19977)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-01","primaryCompletion":"2013-08","completion":"2013-08","firstPosted":"2012-08-17","resultsPosted":"2015-10-02","lastUpdate":"2016-11-02"},"enrollment":6,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Juvenile Idiopathic Arthritis"],"interventions":[{"type":"DRUG","name":"tocilizumab [RoActemra/Actemra]","otherNames":[]}],"arms":[{"label":"RoActemra/Actemra","type":"EXPERIMENTAL"}],"summary":"This long-term, open-label extension study will evaluate the safety of RoActemra/Actemra (tocilizumab) in patients with polyarticular-course juvenile idiopathic arthritis who completed the WA19977 core study. Patients aged 9-18 years with at least JIA ACR30 clinical response to RoActemra/Actemra in the core study will be eligible to receive RoActemra/Actemra 8 mg/kg intravenously every 4 weeks. Anticipated time on study treatment is 104 weeks.","primaryOutcome":{"measure":"Number of Participants With Adverse Events of Special Interest and Study-Drug Related Adverse Events","timeFrame":"Baseline and every 4 weeks up to Week 76 and Final Follow-Up Visit (up to 82 weeks)","effectByArm":[{"arm":"Tocilizumab","deltaMin":6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"9 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":10},"locations":{"siteCount":3,"countries":["Germany"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":7},"commonTop":["Gastroenteritis","Arthralgia","Upper respiratory tract infection","Juvenile idiopathic arthritis","Abdominal pain"]}}